Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology)
Elisabetta Perrucci,Gabriella Macchia,Annamaria Cerrotta,Angela Damiana Andrulli,Rosa Autorino,Amelia Barcellini,Maura Campitelli,Giulia Corrao,Sara Costantini,Vitaliana De Sanctis,Jacopo Di Muzio,Valeria Epifani,Patrizia Ferrazza,Andrei Fodor,Elisabetta Garibaldi,Concetta Laliscia,Roberta Lazzari,Elena Magri,Cristina Mariucci,Maria Paola Pace,Brigida Pappalardi,Alice Pastorino,Federica Piccolo,Claudio Scoglio,Alessia Surgo,Francesca Titone,Francesca Tortoreto,Francesca De Felice,Cynthia Aristei
DOI: https://doi.org/10.1007/s11547-024-01844-5
Abstract:Multi-modal therapies for gynecological cancers management may determine a wide range of side effects which depend on therapy-related factors and patient characteristics and comorbidities. Curative or adjuvant pelvic radiotherapy is linked with acute and late toxicity due to irradiation of organs at risk, as small and large bowel, rectum, bladder, pelvic bone, vagina and bone marrow. Successful toxicity management varies with its severity, Radiation Centre practice and experience and skills of radiation oncologists. This position paper was designed by the Italian Association of Radiation and Clinical Oncology Gynecology Study Group to provide radiation oncologists with evidence-based strategies to prevent and manage acute and late toxicities and follow-up recommendations for gynecological cancer patients submitted radiotherapy. Six workgroups of radiation oncologists with over 5 years of experience in gynecologic cancers were setup to investigate radiotherapy-related toxicities. For each topic, PubMed database was searched for relevant English language papers from January 2005 to December 2022. Titles and abstracts of results were checked to verify suitability for the document. Reference lists of selected studies and review papers were added if pertinent. Data on incidence, etiopathogenesis, prevention, treatment and follow-up of acute and late side effects for each organ at risk are presented and discussed.